Can you provide the upcoming earnings date for APPLIED DNA SCIENCES INC?
APPLIED DNA SCIENCES INC (APDN) will report earnings on 2025-12-15, after the market close.
APPLIED DNA SCIENCES INC (APDN) Forecast, Price Target & Analyst Ratings
NASDAQ:APDN • US03815U6073
Current stock price
5.62 USD
+1.35 (+31.62%)
At close:
6.18 USD
+0.56 (+9.96%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APPLIED DNA SCIENCES INC (APDN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Dec 15, 2025
- Period
- Q4 / 2025
- EPS Estimate
- -$22.95
- Revenue Estimate
- 1.659M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $5.62 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
APDN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about APDN.
In the previous month the buy percentage consensus was at a similar level.
APDN was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-06-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-22 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-12 | Roth Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Dec 15, 2025
- Period
- Q4 / 2025
- EPS Estimate
- -$22.95
- Revenue Estimate
- 1.659M
- Revenue Q2Q
- 104.03%
- EPS Q2Q
- 90.44%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
APDN is expected to report earnings on 12/15/2025. The consensus EPS estimate for the next earnings is -22.95 USD and the consensus revenue estimate is 1.66M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.169M 101.25% | 13.367M -26.43% | 3.431M -74.33% | 5.39M 57.08% | 7.546M 40.00% | |
| EBITDA YoY % growth | -12.68M -10.75% | -9.591M 24.36% | -13.328M -38.97% | N/A | N/A | |
| EBIT YoY % growth | -13.97M -13.64% | -10.953M 21.60% | -14.025M -28.05% | -11.897M 15.17% | -10.815M 9.10% | |
| Operating Margin | -76.89% | -81.94% | -408.72% | -220.73% | -143.32% | |
| EPS YoY % growth | -15,000.00 48.77% | -11,250.00 25.00% | -5,220.00 53.60% | -367.20 92.97% | -84.15 77.08% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -22.95 90.44% |
| Revenue Q2Q % growth | 1.659M 104.03% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -2.683M 18.00% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
APPLIED DNA SCIENCES INC / APDN Forecast FAQ
What are the consensus estimates for APPLIED DNA SCIENCES INC (APDN) next earnings?
The consensus EPS estimate for the next earnings of APPLIED DNA SCIENCES INC (APDN) is -22.95 USD and the consensus revenue estimate is 1.66M USD.
What is the consensus rating for APDN stock?
The consensus rating for APPLIED DNA SCIENCES INC (APDN) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.